Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Interest Coverage Ratio of 4.8 for Q1 2026, up 103.56% year-over-year from 2.36 in Q1 2025, and up 160.22% quarter-over-quarter from 7.98 in Q4 2025.
Vivos Therapeutics (VVOS) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Interest Coverage Ratio for 7 consecutive years, with 4.8 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 103.56% year-over-year to 4.8; the TTM figure through Mar 2026 stood at 16.41 (up 104.21% YoY), while the FY2025 annual figure was 9.88, up 2003.06% from the prior year.
- Interest Coverage Ratio grew to 4.8 in Q1 2026 per VVOS's latest filing, from 7.98 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 14.01 in Q3 2025 and bottomed at 135.1 in Q1 2025.
- Historically, Interest Coverage Ratio has averaged 20.69 across 5 years, with a median of 6.3 in 2024.
- On a YoY basis, Interest Coverage Ratio climbed as much as 270.88% in 2025 and fell as far as 7759.92% in 2025.
- Vivos Therapeutics' Interest Coverage Ratio stood at 13.91 in 2022, then surged by 89.56% to 1.45 in 2023, then slumped by 218.91% to 4.63 in 2024, then slumped by 72.29% to 7.98 in 2025, then surged by 160.22% to 4.8 in 2026.
- Business Quant data shows VVOS's Interest Coverage Ratio at 4.8 in Q1 2026, 7.98 in Q4 2025, and 14.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 4.82 |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 11.77 |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 10.64 |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 12.27 |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | - |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 6.48 |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -8.96 |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 18.09 |
| 10 | Vivos Therapeutics | 5.18 Mn | 3.38 Mn | 2.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.80 |
| Dec 31, 2025 | -7.98 |
| Sep 30, 2025 | 14.01 |
| Jun 30, 2025 | 6.71 |
| Mar 31, 2025 | -135.10 |
| Dec 31, 2024 | -4.63 |
| Sep 30, 2024 | -91.21 |
| Jun 30, 2024 | -3.93 |
| Mar 31, 2024 | -1.72 |
| Sep 30, 2023 | -1.45 |
| Jun 30, 2023 | -1.70 |
| Mar 31, 2023 | -10.13 |
| Dec 31, 2022 | -13.91 |
| Sep 30, 2022 | -8.27 |
| Jun 30, 2022 | -10.08 |
| Mar 31, 2022 | -66.39 |
| Dec 31, 2021 | -1,852.75 |
| Sep 30, 2021 | -2.82 |
| Jun 30, 2021 | -3.55 |
| Mar 31, 2021 | -34.06 |